SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-034902
Filing Date
2024-09-04
Accepted
2024-09-03 21:54:28
Documents
60
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 844044
2 ex31-1.htm EX-31.1 11605
3 ex31-2.htm EX-31.2 11491
4 ex32-1.htm EX-32.1 6249
5 ex32-2.htm EX-32.2 6179
  Complete submission text file 0001493152-24-034902.txt   5090596

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE shph-20240630.xsd EX-101.SCH 33926
7 XBRL CALCULATION FILE shph-20240630_cal.xml EX-101.CAL 50825
8 XBRL DEFINITION FILE shph-20240630_def.xml EX-101.DEF 206962
9 XBRL LABEL FILE shph-20240630_lab.xml EX-101.LAB 320764
10 XBRL PRESENTATION FILE shph-20240630_pre.xml EX-101.PRE 275845
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 753805
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41488 | Film No.: 241275760
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)